Twist to offer RNA control for U.K. strain of SARS-CoV-2

By The Science Advisory Board staff writers

Twist Bioscience plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2 circulating in the U.K. and South Africa.

The newly identified strain of the virus contains multiple spike protein mutations, as well as mutations in other areas of the viral genome, and may increase SARS-CoV-2 transmissibility by up to 70%.

Twist said it expects the new control to be available by January 15, 2021.

Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking